KPIs & Operating Metrics(New)
Aesthetics Revenue By CategoryAesthetics Revenue By Category AnnualAesthetics Revenue By GeographyAesthetics Revenue By Geography AnnualBreakdown Of AssetsEmployee StatisticsEye Care Revenue By CategoryEye Care Revenue By Category AnnualEye Care Revenue By GeographyEye Care Revenue By Geography AnnualGross MarginGross Margin %Gross Margin AnnualGross Margin Annual %Hematology Oncology Revenue By CategoryHematology Oncology Revenue By Category AnnualHematology Oncology Revenue By GeographyHematology Oncology Revenue By Geography AnnualImmunology Revenue By CategoryImmunology Revenue By Category AnnualImmunology Revenue By GeographyImmunology Revenue By Geography AnnualIncome Before Income Taxes By RegionLong Lived Assets By RegionNeuroscience Revenue By CategoryNeuroscience Revenue By Category AnnualNeuroscience Revenue By GeographyNeuroscience Revenue By Geography AnnualNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX SegregationOther Key Products Revenue By CategoryOther Key Products Revenue By Category AnnualOther Key Products Revenue By GeographyOther Key Products Revenue By Geography AnnualProperty & Equipment BreakdownRevenueRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Ship To LocationRevenue By Ship To Location %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Gross Margin (2016 - 2025)

AbbVie (ABBV) has disclosed Gross Margin for 14 consecutive years, with 72.61% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 172.0% to 72.61% in Q4 2025 year-over-year; TTM through Dec 2025 was 70.24%, a 24.0% increase, with the full-year FY2025 number at 70.24%, up 24.0% from a year prior.
  • Gross Margin was 72.61% for Q4 2025 at AbbVie, up from 66.38% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 72.61% in Q4 2025 to a low of 53.44% in Q3 2023.
  • A 5-year average of 68.31% and a median of 69.71% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: crashed -1266bps in 2023, then soared 1744bps in 2024.
  • AbbVie's Gross Margin stood at 70.98% in 2021, then increased by 2bps to 72.42% in 2022, then dropped by -17bps to 60.11% in 2023, then rose by 18bps to 70.89% in 2024, then increased by 2bps to 72.61% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Gross Margin are 72.61% (Q4 2025), 66.38% (Q3 2025), and 71.82% (Q2 2025).